Login / Signup

Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1.

Jamal GhoumidMorgane StichelboutAnne-Sophie JourdainFrederic FrenoisSophie Lejeune-DumoulinMarie-Pierre Alex-CordierMarine LebrunPierre GuerreschiVeronique Duquennoy-MartinotMatthieu VinchonJoel FerriMatthieu JungSerge VicaireClemence VanlerbergheFabienne EscandeFlorence PetitSylvie Manouvrier-Hanu
Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2017)
Mutations in CDH1 encoding the E-cadherin were previously reported in hereditary diffuse gastric cancer as well as in nonsyndromic cleft lip/palate. Mutations in CTNND1 have never been reported before. The encoded protein, p120ctn, prevents E-cadherin endocytosis and stabilizes its localization at the cell surface. Conditional deletion of Cdh1 and Ctnnd1 in various animal models induces features reminiscent of BCD syndrome and underlines critical role of the E-cadherin-p120ctn interaction in eyelid, craniofacial, and tooth development. Our data assert BCD syndrome as a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1 and widen the phenotypic spectrum of E-cadherin anomalies.Genet Med advance online publication 09 March 2017.
Keyphrases
  • cell surface
  • case report
  • healthcare
  • social media
  • low grade
  • binding protein
  • health information
  • high grade
  • drug induced